Effect of antiplatelet therapy on the incidence, prognosis, and rebleeding of intracerebral hemorrhage.
Yunjie LiXia LiuShiling ChenJingyi WangChao PanGaigai LiZhouping TangPublished in: CNS neuroscience & therapeutics (2023)
This review thoroughly discusses the relationship between APT and the development of ICH, the impact of APT on the course and prognosis of ICH patients, and the factors influencing the decision to restart APT after ICH. However, different studies' conclusions are inconsistent due to the differences in quality control. To support future clinical decisions, more large-scale randomized controlled trials are required.
Keyphrases
- antiplatelet therapy
- quality control
- end stage renal disease
- acute coronary syndrome
- percutaneous coronary intervention
- randomized controlled trial
- ejection fraction
- chronic kidney disease
- risk factors
- prognostic factors
- peritoneal dialysis
- brain injury
- clinical trial
- current status
- coronary artery disease
- atrial fibrillation
- study protocol